Does resection enhance the response of the intestine to urogastrone-epidermal growth factor in the rat?
- 1 August 1988
- journal article
- research article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 75 (2) , 121-126
- https://doi.org/10.1042/cs0750121
Abstract
The objective of this study was to see whether another proliferative stimulus could modify the marked proliferative effect of human epidermal growth factor (urogastrone-epidermal growth factor, URO-EGF) on the gastrointestinal epithelium. The response of the gastrointestinal tract to URO-EGF was investigated in rats maintained on total parenteral nutrition (TPN) with or without 75% small bowel resection. Continuous infusion of 60 .mu.g of recombinant .beta.-urogastrone/day per rat increased proliferation in the stomach by over four times (P < 0.01), doubled proliferation in the small intestine (P < 0.001) and increased in the control group. No significant effect of urogastrone was observed in the stomach of the resected groups, but proliferation was also increased in the small intestine by one and a half times (P < 0.001) and by nearly four times in the colon (P < 0.001). Two-way analysis of variance showed that resection had a significant effect (P < 0.01) on proliferation below the anastomosis and in the ileum. However, the response of the ileum was only half that observed in orally fed rats, which confirms the importance of ''luminal nutrition'' in the response to resection. Intestinal resection in the TPN rat was associated with a small rise in plasma enteroglucagon levels, suggesting that this hormone may be implicated in the adaptive response of the small intestine to resection. However, the proliferative effects of URO-EGF were not associated with increased plasma enteroglucagon and thus the two agents probably exert their proliferative effects via separate mechanisms. There was no evidence for a significant positive interaction between the effects of URO-EGF and resection. Thus loss of intestinal mass had no influence on the susceptibility of the intestine to the effects of URO-EGF. Although URO-EGF significantly increased intestinal epithelial cell proliferation, it could not entirely compensate for the lack of luminal centers.This publication has 10 references indexed in Scilit:
- Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats.Gut, 1987
- Epidermal growth factor measurements in mouse plasma: method, ontogeny, and sex differenceAmerican Journal of Physiology-Endocrinology and Metabolism, 1985
- TOTAL PARENTERAL-NUTRITION INHIBITS INTESTINAL ADAPTIVE HYPERPLASIA IN YOUNG-RATS - REVERSAL BY FEEDING1984
- Comparison of single time point and linear regression estimates of cell production in rat intestinal crypts after perturbation by hydroxyureaVirchows Archiv B Cell Pathology Including Molecular Pathology, 1984
- The effects of starvation and refeeding on intestinal cell proliferation in the mouseVirchows Archiv B Cell Pathology Including Molecular Pathology, 1984
- Quantitation of Epidermal Growth Factor in the RatScandinavian Journal of Gastroenterology, 1983
- Epidermal Growth Factor Is a Major Growth-Promoting Agent in Human MilkScience, 1980
- Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands.Gut, 1978
- Glucagon levels in normal and diabetic subjects: Use of a specific immunoabsorbent for glucagon radioimmunoassayDiabetologia, 1977
- Effects of Oral Versus Intravenous Nutrition on Intestinal Adaptation After Small Bowel Resection in the DogGastroenterology, 1976